Search

everythinglearnresearchcommunity

for

Search:↓

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Future acne treatments should aggressively target inflammation to prevent scarring.

PCOS causes inflammation regardless of body weight.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Clascoterone may be an effective topical treatment for hair loss.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New compounds may help treat prostate issues without affecting androgen receptors.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New steroids were effective in blocking male hormone receptors in hamster prostates.

A new compound effectively inhibits human 5α-reductase 1.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The treatment helped promote hair growth in men with androgenetic alopecia.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.